Publications by authors named "Massimo Catarini"

Claim this Profile
O
Overall survival of myelodysplastic syndrome patients after azacitidine discontinuation and applicability of the North American MDS Consortium scoring system in clinical practice.
Marino Clavio, Elena Crisà, Maurizio Miglino, Fabio Guolo, Manuela Ceccarelli, Massimo Catarini

Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced dementia: opinions of physicians and nurses about antibiotic therapy, artificial hydration and nutrition in patients with different life expectancies.
Valentina Pengo, Anna Zurlo, Alberto Voci, Elisabetta Valentini, Francesca De Zaiacomo, Massimo Catarini

Geriatr Gerontol Int· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial nutrition and hydration in terminally ill patients with advanced dementia: opinions and correlates among Italian physicians and nurses.
Elisabetta Valentini, Valter Giantin, Alberto Voci, Mario Iasevoli, Anna Zurlo, Massimo Catarini

J Palliat Med· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromes.
Antonella Poloni, Gaia Goteri, Antonio Zizzi, Federica Serrani, Silvia Trappolini, Massimo Catarini

Eur J Haematol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
6q deletion detected by fluorescence in situ hybridization using bacterial artificial chromosome in chronic lymphocytic leukemia.
Alessia Dalsass, Francesca Mestichelli, Miriana Ruggieri, Paola Gaspari, Valerio Pezzoni, Massimo Catarini

Eur J Haematol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tailored therapy in an unselected population of 91 elderly patients with DLBCL prospectively evaluated using a simplified CGA.
Attilio Olivieri, Guido Gini, Caterina Bocci, Mauro Montanari, Silvia Trappolini, Massimo Catarini

Oncologist· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of vulnerability measures and their effect on survival in a real-life population of multiple myeloma patients registered at Marche Region Multiple Myeloma Registry.
Massimo Offidani, Laura Corvatta, Claudia Polloni, Riccardo Centurioni, Giuseppe Visani, Massimo Catarini

Clin Lymphoma Myeloma Leuk· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of melphalan, thalidomide and prednisone combined with oral panobinostat in patients with relapsed/refractory multiple myeloma.
Massimo Offidani, Claudia Polloni, Federica Cavallo, Anna Marina Liberati, Stelvio Ballanti, Massimo Catarini

Leuk Lymphoma· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thalidomide, dexamethasone, Doxil and Velcade (ThaDD-V) followed by consolidation/maintenance therapy in patients with relapsed-refractory multiple myeloma.
Massimo Offidani, Laura Corvatta, Claudia Polloni, Silvia Gentili, Anna Mele, Massimo Catarini

Ann Hematol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infectious complications in patients with multiple myeloma treated with new drug combinations containing thalidomide.
Massimo Offidani, Laura Corvatta, Claudia Polloni, Silvia Gentili, Annamaria Brioni, Massimo Catarini

Leuk Lymphoma· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melphalan, prednisone, and thalidomide versus thalidomide, dexamethasone, and pegylated liposomal doxorubicin regimen in very elderly patients with multiple myeloma: a case-match study.
Massimo Offidani, Pietro Leoni, Sara Bringhen, Laura Corvatta, Alessandra Larocca, Massimo Catarini

Leuk Lymphoma· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
ThaDD plus high dose therapy and autologous stem cell transplantation does not appear superior to ThaDD plus maintenance in elderly patients with de novo multiple myeloma.
Massimo Offidani, Pietro Leoni, Laura Corvatta, Claudia Polloni, Silvia Gentili, Massimo Catarini

Eur J Haematol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thalidomide-dexamethasone versus interferon-alpha-dexamethasone as maintenance treatment after ThaDD induction for multiple myeloma: a prospective, multicentre, randomised study.
Massimo Offidani, Laura Corvatta, Claudia Polloni, Maria-Novella Piersantelli, Silvia Gentili, Massimo Catarini

Br J Haematol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum C-reactive protein at diagnosis and response to therapy is the most powerful factor predicting outcome of multiple myeloma treated with thalidomide/ anthracycline-based therapy.
Massimo Offidani, Laura Corvatta, Claudia Polloni, Maria-Novella Piersantelli, Piero Galieni, Massimo Catarini

Clin Lymphoma Myeloma· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
R-COMP 21 for frail elderly patients with aggressive B-cell non-Hodgkin lymphoma: a pilot study.
Giuseppe Visani, Felicetto Ferrara, Francesco Alesiani, Sonia Ronconi, Massimo Catarini

Leuk Lymphoma· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Technetium-99m sestamibi scintigraphy is sensitive and specific for the staging and the follow-up of patients with multiple myeloma: a multicentre study on 397 scans.
Anna Mele, Massimo Offidani, Giuseppe Visani, Monica Marconi, Filippo Cambioli, Massimo Catarini

Br J Haematol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thalidomide, dexamethasone, and pegylated liposomal doxorubicin (ThaDD) for patients older than 65 years with newly diagnosed multiple myeloma.
Massimo Offidani, Laura Corvatta, Maria-Novella Piersantelli, Giuseppe Visani, Francesco Alesiani, Massimo Catarini

Blood· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose thalidomide with pegylated liposomal doxorubicin and high-dose dexamethasone for relapsed/refractory multiple myeloma: a prospective, multicenter, phase II study.
Massimo Offidani, Laura Corvatta, Monica Marconi, Giuseppe Visani, Francesco Alesiani, Massimo Catarini

Haematologica· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thalidomide plus oral melphalan compared with thalidomide alone for advanced multiple myeloma.
Massimo Offidani, Laura Corvatta, Monica Marconi, Attilio Olivieri, Massimo Catarini

Hematol J· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of two regimens for the treatment of elderly patients with acute lymphoblastic leukaemia (ALL).
Massimo Offidani, Laura Corvatta, Lara Malerba, Monica Marconi, Massimo Catarini

Leuk Lymphoma· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Common and rare side-effects of low-dose thalidomide in multiple myeloma: focus on the dose-minimizing peripheral neuropathy.
Massimo Offidani, Laura Corvatta, Monica Marconi, Lara Malerba, Anna Mele, Massimo Catarini

Eur J Haematol· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thalidomide plus oral melphalan for advanced multiple myeloma: a phase II study.
Massimo Offidani, Monica Marconi, Laura Corvatta, Attilio Olivieri, Massimo Catarini

Haematologica· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis